Mitigation of gastrointestinal graft versus host disease with tocilizumab prophylaxis is accompanied by preservation of microbial diversity and attenuation of enterococcal domination

Saurabh Chhabra, Aniko Szabo, Annelie Clurman, Katelynn McShane, Nicholas Waters, Daniel Eastwood, Lisa Samanas, Teng Fei, Gabriel Armijo, Sameen Abedin, Walter Longo, Parameswaran Hari, Mehdi Hamadani, Nirav N. Shah, Lyndsey Runaas, James H. Jerkins, Marcel van den Brink, Jonathan U. Peled, William R. Drobyski
doi: https://doi.org/10.1101/2022.06.30.22277104

Article usage

Article usage: July 2022 to June 2025

AbstractFullPdf
Jul 2022483746
Aug 2022149526
Sep 2022181419
Oct 20221391513
Nov 20221319516
Dec 20227445
Jan 20236664
Feb 20235468
Mar 20236369
Apr 20232563
May 202318126
Jun 20231666
Jul 2023958
Aug 2023292120
Sep 202325914
Oct 20231395
Nov 202324198
Dec 20231508
Jan 2024732
Feb 20241153
Mar 202417611
Apr 2024652
May 2024542
Jun 202438159
Jul 2024281314
Aug 20241499
Sep 20241865
Oct 20245117
Nov 20241479
Dec 2024566
Jan 2025132110
Feb 20259395
Mar 202520379
Apr 2025191914
May 202523307
Jun 2025547
Back to top
Posted July 02, 2022.
Download PDF

Supplementary Material

Data/Code
Email
Mitigation of gastrointestinal graft versus host disease with tocilizumab prophylaxis is accompanied by preservation of microbial diversity and attenuation of enterococcal domination
Saurabh Chhabra, Aniko Szabo, Annelie Clurman, Katelynn McShane, Nicholas Waters, Daniel Eastwood, Lisa Samanas, Teng Fei, Gabriel Armijo, Sameen Abedin, Walter Longo, Parameswaran Hari, Mehdi Hamadani, Nirav N. Shah, Lyndsey Runaas, James H. Jerkins, Marcel van den Brink, Jonathan U. Peled, William R. Drobyski
medRxiv 2022.06.30.22277104; doi: https://doi.org/10.1101/2022.06.30.22277104
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area